Wednesday, October 27, 2010
Glaxo To Pay $750M For Manufacturing Fraud
GlaxoSmithKline has agreed to pay a $750 million fine to settle charges over numerous production problems - contaminated meds, mislabeled packaging and incorrect dosages - at a facility in Cidra, Puerto Rico. For more on the story go to Pharmalot, Law.com, FDA Law Blog, AboutLawsuits.com and the Wall Street Journal Law Blog.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment